<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">9261417</PMID><DateCompleted><Year>1997</Year><Month>09</Month><Day>17</Day></DateCompleted><DateRevised><Year>2020</Year><Month>07</Month><Day>24</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0022-538X</ISSN><JournalIssue CitedMedium="Print"><Volume>71</Volume><Issue>9</Issue><PubDate><Year>1997</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Journal of virology</Title><ISOAbbreviation>J Virol</ISOAbbreviation></Journal><ArticleTitle>Poliovirus Sabin type 1 neutralization epitopes recognized by immunoglobulin A monoclonal antibodies.</ArticleTitle><Pagination><StartPage>6905</StartPage><EndPage>6912</EndPage><MedlinePgn>6905-12</MedlinePgn></Pagination><Abstract><AbstractText>Immunity to poliomyelitis is largely dependent on humoral neutralizing antibodies, both after natural (wild virus or vaccine) infection and after inactivated poliovirus vaccine inoculation. Although the production of local secretory immunoglobulin A (IgA) antibody in the gut mucosa may play a major role in protection, most of information about the antigenic determinants involved in neutralization of polioviruses derives from studies conducted with humoral monoclonal antibodies (MAbs) generated from parenterally immunized mice. To investigate the specificity of the mucosal immune response to the virus, we have produced a library of IgA MAbs directed at Sabin type 1 poliovirus by oral immunization of mice with live virus in combination with cholera toxin. The epitopes recognized by 13 neutralizing MAbs were characterized by generating neutralization-escape virus mutants. Cross-neutralization analysis of viral mutants with MAbs allowed these epitopes to be divided into four groups of reactivity. To determine the epitope specificity of MAbs, virus variants were sequenced and the mutations responsible for resistance to the antibodies were located. Eight neutralizing MAbs were found to be directed at neutralization site N-AgIII in capsid protein VP3; four more MAbs recognized site N-AgII in VP1 or VP2. One IgA MAb selected a virus variant which presented a unique mutation at amino acid 138 in VP2, not previously described. This site appears to be partially related with site N-AgII and is located in a loop region facing the VP2 N-Ag-II loop around residue 164. Only 2 of 13 MAbs proved able to neutralize the wild-type Mahoney strain of poliovirus. The IgA antibodies studied were found to be produced in the dimeric form needed for recognition by the polyimmunoglobulin receptor mediating secretory antibody transport at the mucosal level.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fiore</LastName><ForeName>L</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Laboratorio di Virologia, Istituto Superiore di Sanit&#xe1;, Rome, Italy. fiore@virus1.net.iss.it</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ridolfi</LastName><ForeName>B</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Genovese</LastName><ForeName>D</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Buttinelli</LastName><ForeName>G</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Lucioli</LastName><ForeName>S</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Lahm</LastName><ForeName>A</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Ruggeri</LastName><ForeName>F M</ForeName><Initials>FM</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Virol</MedlineTA><NlmUniqueID>0113724</NlmUniqueID><ISSNLinking>0022-538X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000911">Antibodies, Monoclonal</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000956">Antigens, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018985">Epitopes, B-Lymphocyte</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007070">Immunoglobulin A</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011055">Poliovirus Vaccine, Oral</NameOfSubstance></Chemical><Chemical><RegistryNumber>2ZD004190S</RegistryNumber><NameOfSubstance UI="D013912">Threonine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000911" MajorTopicYN="N">Antibodies, Monoclonal</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000918" MajorTopicYN="N">Antibody Specificity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000956" MajorTopicYN="N">Antigens, Viral</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002213" MajorTopicYN="N">Capsid</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018985" MajorTopicYN="N">Epitopes, B-Lymphocyte</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007070" MajorTopicYN="N">Immunoglobulin A</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008807" MajorTopicYN="N">Mice, Inbred BALB C</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009500" MajorTopicYN="N">Neutralization Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017955" MajorTopicYN="N">Poliovirus</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011055" MajorTopicYN="N">Poliovirus Vaccine, Oral</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011487" MajorTopicYN="N">Protein Conformation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013912" MajorTopicYN="N">Threonine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014407" MajorTopicYN="N">Tumor Cells, Cultured</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1997</Year><Month>9</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1997</Year><Month>9</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1997</Year><Month>9</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>1997</Year><Month>9</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">9261417</ArticleId><ArticleId IdType="pmc">PMC191973</ArticleId><ArticleId IdType="doi">10.1128/JVI.71.9.6905-6912.1997</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Proc Natl Acad Sci U S A. 1992 Aug 1;89(15):6901-5</Citation><ArticleIdList><ArticleId IdType="pubmed">1323121</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 1996 Apr 5;272(5258):104-7</Citation><ArticleIdList><ArticleId IdType="pubmed">8600516</ArticleId></ArticleIdList></Reference><Reference><Citation>Immunology. 1986 Oct;59(2):301-8</Citation><ArticleIdList><ArticleId IdType="pubmed">3021614</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 1970 Aug 15;227(5259):680-5</Citation><ArticleIdList><ArticleId IdType="pubmed">5432063</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 1991 Apr;65(4):2146-8</Citation><ArticleIdList><ArticleId IdType="pubmed">2002558</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Top Microbiol Immunol. 1990;161:121-54</Citation><ArticleIdList><ArticleId IdType="pubmed">2169382</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 1956 Jun 29;123(3209):1151-7</Citation><ArticleIdList><ArticleId IdType="pubmed">13337331</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 1997 Feb;175 Suppl 1:S165-72</Citation><ArticleIdList><ArticleId IdType="pubmed">9203711</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 1994 May 28;343(8909):1331-7</Citation><ArticleIdList><ArticleId IdType="pubmed">7910329</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 1985 Jun;54(3):856-9</Citation><ArticleIdList><ArticleId IdType="pubmed">2987536</ArticleId></ArticleIdList></Reference><Reference><Citation>Gastroenterology. 1990 Jan;98(1):56-8</Citation><ArticleIdList><ArticleId IdType="pubmed">2152776</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Immunol. 1990 Feb;20(2):433-6</Citation><ArticleIdList><ArticleId IdType="pubmed">2311649</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 1986 Oct;60(1):297-301</Citation><ArticleIdList><ArticleId IdType="pubmed">3018295</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 1985 Sep 27;229(4720):1358-65</Citation><ArticleIdList><ArticleId IdType="pubmed">2994218</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 1955 Jul 15;122(3159):105-8</Citation><ArticleIdList><ArticleId IdType="pubmed">14385825</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Immunol. 1984 Apr;14(4):350-6</Citation><ArticleIdList><ArticleId IdType="pubmed">6609824</ArticleId></ArticleIdList></Reference><Reference><Citation>Physiol Rev. 1992 Oct;72(4):853-79</Citation><ArticleIdList><ArticleId IdType="pubmed">1438580</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 1985 Sep 13;229(4718):1090-3</Citation><ArticleIdList><ArticleId IdType="pubmed">2412292</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 1988 Sep;62(9):3536-9</Citation><ArticleIdList><ArticleId IdType="pubmed">2841503</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 1991 Oct 1;88(19):8796-800</Citation><ArticleIdList><ArticleId IdType="pubmed">1924341</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 1982 Oct;79(19):5793-7</Citation><ArticleIdList><ArticleId IdType="pubmed">6310545</ArticleId></ArticleIdList></Reference><Reference><Citation>Virology. 1996 Nov 1;225(1):97-110</Citation><ArticleIdList><ArticleId IdType="pubmed">8918537</ArticleId></ArticleIdList></Reference><Reference><Citation>J Gen Virol. 1985 May;66 ( Pt 5):1159-65</Citation><ArticleIdList><ArticleId IdType="pubmed">2582084</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 1991 May;65(5):2707-10</Citation><ArticleIdList><ArticleId IdType="pubmed">1850043</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 1981 Jun 18;291(5816):547-53</Citation><ArticleIdList><ArticleId IdType="pubmed">6264310</ArticleId></ArticleIdList></Reference><Reference><Citation>J Mol Biol. 1977 May 25;112(3):535-42</Citation><ArticleIdList><ArticleId IdType="pubmed">875032</ArticleId></ArticleIdList></Reference><Reference><Citation>J Gen Virol. 1986 Jul;67 ( Pt 7):1283-91</Citation><ArticleIdList><ArticleId IdType="pubmed">2425046</ArticleId></ArticleIdList></Reference><Reference><Citation>Antimicrob Agents Chemother. 1990 Mar;34(3):460-6</Citation><ArticleIdList><ArticleId IdType="pubmed">2159258</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 1983 Aug 4-10;304(5925):459-62</Citation><ArticleIdList><ArticleId IdType="pubmed">6192344</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 1987 Dec;61(12):3749-53</Citation><ArticleIdList><ArticleId IdType="pubmed">2824812</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 1988 May;62(5):1781-94</Citation><ArticleIdList><ArticleId IdType="pubmed">2451757</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 1971 Jul;107(1):123-30</Citation><ArticleIdList><ArticleId IdType="pubmed">5091954</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 1990 Mar;64(3):1283-9</Citation><ArticleIdList><ArticleId IdType="pubmed">1689392</ArticleId></ArticleIdList></Reference><Reference><Citation>Virology. 1989 Jun;170(2):583-6</Citation><ArticleIdList><ArticleId IdType="pubmed">2471354</ArticleId></ArticleIdList></Reference><Reference><Citation>Annu Rev Public Health. 1992;13:239-52</Citation><ArticleIdList><ArticleId IdType="pubmed">1599587</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Immunol. 1988 Mar;8(2):89-94</Citation><ArticleIdList><ArticleId IdType="pubmed">2836474</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 1985 Dec;152(6):1238-44</Citation><ArticleIdList><ArticleId IdType="pubmed">2999260</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 1983 Aug;47(2):267-75</Citation><ArticleIdList><ArticleId IdType="pubmed">6312065</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 1983 Feb 24;301(5902):674-9</Citation><ArticleIdList><ArticleId IdType="pubmed">6186919</ArticleId></ArticleIdList></Reference><Reference><Citation>Virology. 1983 Apr 30;126(2):707-10</Citation><ArticleIdList><ArticleId IdType="pubmed">6190311</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>